Rethinking secondary immunodeficiency: a cross-domain pathway framework for risk stratification
BackgroundSecondary immunodeficiency (SID) arises from malignancy, immunomodulatory therapies, organ dysfunction, chronic infection, malnutrition, and aging. Despite its increasing prevalence, SID remains conceptualized within disease-specific silos, r…